Skip to main content
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    India
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
    Tuberculosis (TB)